“…The assays make use of either a ligand coupled to an enzyme [42] or measure receptor-ligand binding based on enzyme activity via an indirect route [43][44][45][46][47]. An example of the latter is described by Mahoney [44] for the platelet-derived growth factor receptor (PDGF-R).…”
“…The assays make use of either a ligand coupled to an enzyme [42] or measure receptor-ligand binding based on enzyme activity via an indirect route [43][44][45][46][47]. An example of the latter is described by Mahoney [44] for the platelet-derived growth factor receptor (PDGF-R).…”
“…Details concerning the procedure for the enzyme binding assay using a biotinylated ligand and the biotin-immobilized microtiter plate (biotin plate) were described in a previous report. 25 The biotin plate was prepared as follows: 0.002% biotin-BSA phosphate buffer solution (pH 7.0) was added to the wells of the microtiter plate (Wako Pure Chem. Co.) and incubated overnight at 4 °C.…”
Section: Procedures Of the Enzyme Binding Assay Using Biotinylated Es...mentioning
confidence: 99%
“…In a previous study, we have described the receptor binding assay for benzodiazepine drugs using this principle. 25 The competitive binding curves for 17b-estradiol, 17b-estradiol-6-one and estradiol-SH obtained by this enzyme binding assay are shown in Fig. 6.…”
Section: Enzyme Binding Assay Using Biotinylated Estradiolmentioning
confidence: 99%
“…[22][23][24] We have previously achieved the receptor binding assay for benzodiazepine drugs based on a solid-phase avidin-biotin binding assay. 25 The same principle was applied to the immunoassay for 17b-estradiol and estradiol antibody in this study.…”
A simple electrochemical immunoassay was demonstrated using a 17beta-estradiol modified electrode. 17beta-estradiol was immobilized on the gold electrode surface with a self-assembly technique. The specific binding between estradiol antibody and 17beta-estradiol on the electrode surface was evaluated by monitoring the change in the electrode response with three hydrophilic redox markers. The decrease in the electrode response for the redox marker was observed, when the antibody was bound to the estradiol self-assembled monolayer (SAM) electrode surface. The change in the electrode response of the redox marker is attributed to the steric hindrance between the antibody on the electrode surface and the redox marker. The relative standard deviation at 30 microg ml(-1) estradiol antibody was 4.1% (n = 3). The competitive reaction between the antigen in the solution and 17beta-estradiol immobilized on the electrode surface for the limited binding sites on the antibody produced an increase in the electrode response with hydroquinone as the marker. The binding affinity of three antigens including 17beta-estradiol to the estradiol antibody was evaluated. Furthermore, the result obtained from this method was compared with the previously reported enzyme binding assay using the biotinylated estradiol and the biotin-immobilized microtiter plate.
“…24 IC 50 was the concentration of the displacing ligand required to inhibit 50% of the probe ligand binding. As a result, IC 50 of the LB to avidin (3.2×10 -10 M) was similar to that of biotin (7.9×10 -10 M).…”
Section: Change In the Electrode Response Of Lb By Interaction With Amentioning
The electrochemical behavior of biotin labeled with ferrocene was investigated at a perfluorosulfonated ionomer (Nafion ® ) film-coated glassy carbon electrode (GCE). The electrode response of the labeled biotin (LB) was improved by about fifty-fold in sensitivity by using a Nafion ® -coated GCE, compared with a plain GCE. It was found by a solid-phase avidin-biotin binding assay that the labeling with ferrocene hardly affected the affinity of a biotin moiety in the labeled biotin to avidin. The avidin-biotin interaction was estimated from the change of the electrode response caused by the formation of a complex with avidin and the labeled biotin. Furthermore, the detection of biotin was performed by a competitive reaction between the labeled biotin and unlabeled biotin for the limited binding sites of avidin.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.